Table of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Dehydrated Alcohol Injection Market: By Treatment Type Market Trends, Size, and Future Outlook
- By Treatment Type Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Treatment Type Definitions, Technology Landscape
- By Treatment Type Market Drivers
- Increasing recommendation of monotherapy injections as first-line treatment per updated guidelines
- Combination therapy allowing enhanced effectiveness and quicker recovery
- By Treatment Type Market Restraints
- Limitations around contraindications and lack of efficacy for certain patient subgroups
Chapter 4. Dehydrated Alcohol Injection Market: By End-User Market Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By End-User Definitions
- By End-User Market Drivers
- Growing demand for emergency stockpiles and outpatient administration
- By End-User Market Restraints
- Budget constraints around procuring injections in resource limited settings
Chapter 5. Dehydrated Alcohol Injection Market: By Distribution Channel Market Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Distribution Channel Definitions
- By Distribution Channel Market Drivers
- Hospital pharmacies well positioned to cater to in-patient administration
- By Distribution Channel Market Restraints
- Prescription-only status hindering over-the-counter pharmacy sales
Chapter 6. Dehydrated Alcohol Injection Market: By Region Market Trends, Size, and Future Outlook
- By Region Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Region Definitions
- North America Dehydrated Alcohol Injection Market
- Drivers: High treatment rates and product availability
- Restraints: Market saturation
- Europe Dehydrated Alcohol Injection Market
- Drivers: Reimbursement policies and strategic reserves
- Restraints: Preference for alternative therapies
- Asia Pacific Dehydrated Alcohol Injection Market
- Drivers: High burden and rising awareness programs
- Restraints: Infrastructural limitations around cold chain supply
Chapter 7. Dehydrated Alcohol Injection Market: Competitive Landscape
- Recovial
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Par Pharmaceutical
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Pyridine China
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Vertellus Holdings
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Shandong Xinhua Pharmaceutical
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Linyi Sanai Pharmceutical
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Xizang Haisco Pharmaceutical
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Nantong Oceans King Pharmaceutical
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Shandong Jewim Pharmaceutical
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
- Jiangsu Hengrui Medicine
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies and Developments
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataInsights Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current (2023) market size is $186 million.
Key growth drivers include rising methanol poisoning cases, favorable treatment guidelines, improved diagnostics, greater production capacity, and launches of novel antidotes.
Low awareness in emerging markets, high costs, use of alternatives in some regions, and regulatory barriers around product approvals.
Monotherapy injections for standalone use.
Recro Pharma, Par Pharmaceutical, Vertellus Holdings, Shandong Xinhua Pharm, Linyi Sanai Pharmaceutical.
The market will grow at a 8.1% CAGR, reaching $346.8 million by 2031.
Key drivers are rising methanol poisoning cases, treatment guidelines recommending injections as first-line, improved diagnostics and production capacity, and new product launches.